Bernhard Müllinger is General Manager and COO of Resyca BV, focused on soft mist inhalers and nasal spray platforms for drug-device combination products. With over 30 years of experience in aerosol drug delivery, he has worked across therapeutic areas such as asthma, vaccination, and pulmonary hypertension. His expertise includes device engineering, deposition modeling, and the development of drug-device combination products. He previously held senior roles at Vectura, Activaero, and Inamed CROs, and serves on the board of the International Society for Aerosols in Medicine (ISAM).